Canada -
français -
Health Canada
apo-sitagliptin comprimé
apotex inc - sitagliptine (phosphate de sitagliptine monohydraté) - comprimé - 25mg - sitagliptine (phosphate de sitagliptine monohydraté) 25mg
Canada -
français -
Health Canada
apo-sitagliptin comprimé
apotex inc - sitagliptine (phosphate de sitagliptine monohydraté) - comprimé - 50mg - sitagliptine (phosphate de sitagliptine monohydraté) 50mg
Canada -
français -
Health Canada
apo-sitagliptin comprimé
apotex inc - sitagliptine (phosphate de sitagliptine monohydraté) - comprimé - 100mg - sitagliptine (phosphate de sitagliptine monohydraté) 100mg
Canada -
français -
Health Canada
pro-sitagliptin malate comprimé
pro doc limitee - sitagliptine (malate de sitagliptine) - comprimé - 25mg - sitagliptine (malate de sitagliptine) 25mg
Canada -
français -
Health Canada
pro-sitagliptin malate comprimé
pro doc limitee - sitagliptine (malate de sitagliptine) - comprimé - 50mg - sitagliptine (malate de sitagliptine) 50mg
Canada -
français -
Health Canada
pro-sitagliptin malate comprimé
pro doc limitee - sitagliptine (malate de sitagliptine) - comprimé - 100mg - sitagliptine (malate de sitagliptine) 100mg
Canada -
français -
Health Canada
ag-sitagliptin comprimé
angita pharma inc. - sitagliptine (chlorhydrate de sitagliptine monohydraté) - comprimé - 25mg - sitagliptine (chlorhydrate de sitagliptine monohydraté) 25mg
Canada -
français -
Health Canada
ag-sitagliptin comprimé
angita pharma inc. - sitagliptine (chlorhydrate de sitagliptine monohydraté) - comprimé - 50mg - sitagliptine (chlorhydrate de sitagliptine monohydraté) 50mg
Canada -
français -
Health Canada
ag-sitagliptin comprimé
angita pharma inc. - sitagliptine (chlorhydrate de sitagliptine monohydraté) - comprimé - 100mg - sitagliptine (chlorhydrate de sitagliptine monohydraté) 100mg
Union européenne -
français -
EMA (European Medicines Agency)
sitagliptin / metformin hydrochloride mylan
mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabète sucré, type 2 - les médicaments utilisés dans le diabète - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. triple thérapie de combinaison) en complément d'un régime alimentaire et l'exercice chez les patients insuffisamment contrôlés sur leur dose maximale tolérée de metformine et une sulphonylurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.